Zimmer Biomet
897 hedge funds and large institutions have $23.4B invested in Zimmer Biomet in 2019 Q1 according to their latest regulatory filings, with 105 funds opening new positions, 300 increasing their positions, 306 reducing their positions, and 71 closing their positions.
198% more call options, than puts
Call options by funds: $159M | Put options by funds: $53.5M
48% more first-time investments, than exits
New positions opened: 105 | Existing positions closed: 71
23% more capital invested
Capital invested by funds: $19B → $23.4B (+$4.38B)
19% more funds holding in top 10
Funds holding in top 10: 16 → 19 (+3)
3% more funds holding
Funds holding: 872 → 897 (+25)
0.4% less ownership
Funds ownership: 92.79% → 92.39% (-0.4%)
2% less repeat investments, than reductions
Existing positions increased: 300 | Existing positions reduced: 306
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$213M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$187M |
| 3 |
HM
HealthCor Management
New York
|
+$95.9M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$78.5M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$76.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$486M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$169M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$90.8M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$79.5M |
| 5 |
JP Morgan Chase
New York
|
-$76.9M |
ZBH Hedge Fund Activity: Q1 2019 in Review
897 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2019, worth a combined $23.4B — up 23% from $19B a quarter earlier.
Buyers outnumbered sellers: 105 funds opened new ZBH positions and 71 closed out — a net gain of 34 holders — while 300 added to existing stakes and 306 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $213M. The largest seller was Longview Partners, cutting an estimated $486M.
- 897 institutional investors held Zimmer Biomet (ZBH) as of Q1 2019, up from 872 in Q4 2018.
- Funds reported $23.4B of Zimmer Biomet stock for Q1 2019, up 23% quarter-over-quarter.
- 105 funds opened new Zimmer Biomet positions in Q1 2019 and 71 closed out, a net change of +34 holders.
- The largest Zimmer Biomet buyer in Q1 2019 was Millennium Management, an estimated $213M added.
- The largest Zimmer Biomet seller in Q1 2019 was Longview Partners, an estimated $486M sold.
Based on aggregated 13F filings for Q1 2019.